8th November, 2018

Esma aims to facilitate the novation of non-cleared OTC derivs to the EU with a temporary clearing obligation exemption
Access this article plus the full FOW Intelligence platform, featuring timely insights, expert analysis, and comprehensive volumes data from 100+ exchanges. Everything you need to make informed decisions.
Already have an account?Log in
